25
GLOBAL BIOCHIP MARKET FORECAST & OPPORTUNITIES 2016 – 2026 MARKET INTELLIGENCE . CONSULTING www.techsciresearch.com

Global Biochip Market Size, Share and Forecast 2026 | TechSci Research

Embed Size (px)

DESCRIPTION

According to #TechSci Research report, the Global Biochip Market, it was valued at USD11694.24 million in 2020 and is expected to reach USD23890.58 million by registering a CAGR of 12.52%. Learn More - https://bit.ly/3ncpASK Visit our website @ https://www.techsciresearch.com/ For more market research news visit our blog: https://techsciblog.com/

Citation preview

PowerPoint Presentation

GLOBAL BIOCHIP MARKET

FORECAST & OPPORTUNITIES

2016 – 2026

MARKET INTELLIGENCE . CONSULTING

www.techsciresearch.com

Scope of Report

Product of Interest (POI): Biochip

Review Period

2016 – 2019

Base Year

2020

Estimated Year

2021

Forecast Period

2022 – 2026

Year Range

A biochip is a collection of miniaturized test sites (microarrays) arranged on a solid substrate that permits many tests to be performed at the same time in order to achieve higher throughput and speed. Typically, a biochip's surface area is no larger than a fingernail. Like a computer chip that can perform millions of mathematical operations in one second, a biochip can perform thousands of biological reactions, such as decoding genes, in a few seconds.

Market Segmentation

REGION

Europe

North America

South America

Middle East & Africa

Asia Pacific

TYPE

DNA Chips

Lab-On-a-Chips

Protein Chips

Others

APPLICATION

Drug Discovery & Development

Disease Diagnostics

Genomics

Proteomics

Others

TECHNOLOGY

Microarray

Microfluidics

END USER

Hospitals & Diagnostics Centres

Academic & Research Institutes

Biotechnology & Pharmaceutical Companies

Others

‹#›

Table of Contents

S. No.ContentsPage No.1. Product Overview (Definition of product and major terminologies used in the report)2. Research Methodology (Detailed description of the methodology used to conduct the research, Raw data backup, list of all secondary sources, List of respondents for primary surveys)3.Impact of COVID-19 on Global Biochip Market 4.Executive Summary (This chapter covers summary of the complete study.)5.Voice of Customer (Brand Awareness, Challenges Faced Post Purchase, Factors Influencing Purchase Decision)6.Global Biochip Market Outlook, 2016-2026F (This chapter includes a brief overview of the product of interest market such as total market’s growth rate, expected growth rate, key growth levers, leading region, top grossing product Type, etc. It includes more of a qualitative information about the market.)6.1.Market Size & Forecast6.1.1.By Value6.2.Market Share & Forecast6.2.1.By Technology (Microarray v/s Microfluidics)6.2.2.By Type (DNA Chips, Lab-On-a-Chips, Protein Chips, Others)6.2.3.By Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Others)6.2.4.By End User (Hospitals & Diagnostics Centres, Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, Others)6.2.5.By Company (2020)6.2.6.By Region6.3. Product Market Map

‹#›

Table of Contents

S. No.ContentsPage No.7.North America Biochip Market Outlook, 2016-2026F7.1.Market Size & Forecast7.1.1.By Value7.2.Market Share & Forecast7.2.1.By Technology7.2.2.By Type7.2.3.By Application7.2.4.By End User7.2.5.By Country 7.3.North America: Country Analysis7.3.1.United States Biochip Market Outlook, 2016-2026F7.3.1.1.Market Size & Forecast7.3.1.1.1.By Value7.3.1.2.Market Share & Forecast7.3.1.2.1.By Technology7.3.1.2.2.By Type7.3.1.2.3.By Application7.3.1.2.4.By End User

‹#›

Table of Contents

S. No.ContentsPage No.7.3.2.Canada Biochip Market Outlook, 2016-2026F7.3.2.1.Market Size & Forecast7.3.2.1.1.By Value7.3.2.2.Market Share & Forecast7.3.2.2.1.By Technology7.3.2.2.2.By Type7.3.2.2.3.By Application7.3.2.2.4.By End User7.3.3.Mexico Biochip Market Outlook, 2016-2026F7.3.3.1.Market Size & Forecast7.3.3.1.1.By Value7.3.3.2.Market Share & Forecast7.3.3.2.1.By Technology7.3.3.2.2.By Type7.3.3.2.3.By Application7.3.3.2.4.By End User

‹#›

Table of Contents

S. No.ContentsPage No.8.Europe Biochip Market Outlook, 2016-2026F8.1.Market Size & Forecast8.1.1.By Value8.2.Market Share & Forecast8.2.1.By Technology8.2.2.By Type8.2.3.By Application8.2.4.By End User8.2.5.By Country 8.3.Europe: Country Analysis8.3.1.France Biochip Market Outlook, 2016-2026F8.3.1.1.Market Size & Forecast8.3.1.1.1.By Value8.3.1.2.Market Share & Forecast8.3.1.2.1.By Technology8.3.1.2.2.By Type8.3.1.2.3.By Application8.3.1.2.4.By End User

‹#›

Table of Contents

S. No.ContentsPage No.8.3.2.Germany Biochip Market Outlook, 2016-2026F8.3.2.1.Market Size & Forecast8.3.2.1.1.By Value8.3.2.2.Market Share & Forecast8.3.2.2.1.By Technology8.3.2.2.2.By Type8.3.2.2.3.By Application8.3.2.2.4.By End User8.3.3.United Kingdom Biochip Market Outlook, 2016-2026F8.3.3.1.Market Size & Forecast8.3.3.1.1.By Value8.3.3.2.Market Share & Forecast8.3.3.2.1.By Technology8.3.3.2.2.By Type8.3.3.2.3.By Application8.3.3.2.4.By End User

‹#›

Table of Contents

S. No. Contents Page No.8.3.4.Italy Biochip Market Outlook, 2016-2026F8.3.4.1.Market Size & Forecast8.3.4.1.1.By Value8.3.4.2.Market Share & Forecast8.3.4.2.1.By Technology8.3.4.2.2.By Type8.3.4.2.3.By Application8.3.4.2.4.By End User8.3.5.Spain Biochip Market Outlook, 2016-2026F8.3.5.1.Market Size & Forecast8.3.5.1.1.By Value8.3.5.2.Market Share & Forecast8.3.5.2.1.By Technology8.3.5.2.2.By Type8.3.5.2.3.By Application8.3.5.2.4.By End User

‹#›

Table of Contents

S. No.ContentsPage No.9.Asia-Pacific Biochip Market Outlook, 2016-2026F9.1.Market Size & Forecast9.1.1.By Value9.2.Market Share & Forecast9.2.1.By Technology9.2.2.By Type9.2.3.By Application9.2.4.By End User9.2.5.By Country 9.3.Asia-Pacific: Country Analysis9.3.1.China Biochip Market Outlook, 2016-2026F9.3.1.1.Market Size & Forecast9.3.1.1.1.By Value9.3.1.2.Market Share & Forecast9.3.1.2.1.By Technology9.3.1.2.2.By Type9.3.1.2.3.By Application9.3.1.2.4.By End User

‹#›

Table of Contents

S. No.ContentsPage No.9.3.2.India Biochip Market Outlook, 2016-2026F9.3.2.1.Market Size & Forecast9.3.2.1.1.By Value9.3.2.2.Market Share & Forecast9.3.2.2.1.By Technology9.3.2.2.2.By Type9.3.2.2.3.By Application9.3.2.2.4.By End User9.3.3.Japan Biochip Market Outlook, 2016-2026F9.3.3.1.Market Size & Forecast9.3.3.1.1.By Value9.3.3.2.Market Share & Forecast9.3.3.2.1.By Technology9.3.3.2.2.By Type9.3.3.2.3.By Application9.3.3.2.4.By End User

‹#›

Table of Contents

S. No.ContentsPage No.9.3.4.South Korea Biochip Market Outlook, 2016-2026F9.3.4.1.Market Size & Forecast9.3.4.1.1.By Value9.3.4.2.Market Share & Forecast9.3.4.2.1.By Technology9.3.4.2.2.By Type9.3.4.2.3.By Application9.3.4.2.4.By End User9.3.5.Australia Biochip Market Outlook, 2016-2026F9.3.5.1.Market Size & Forecast9.3.5.1.1.By Value9.3.5.2.Market Share & Forecast9.3.5.2.1.By Technology9.3.5.2.2.By Type9.3.5.2.3.By Application9.3.5.2.4.By End User

‹#›

Table of Contents

S. No.ContentsPage No.10.South America Biochip Market Outlook, 2016-2026F10.1.Market Size & Forecast10.1.1.By Value10.2.Market Share & Forecast10.2.1.By Technology10.2.2.By Type10.2.3.By Application10.2.4.By End User10.2.5.By Country 10.3.South America: Country Analysis10.3.1.Brazil Biochip Market Outlook, 2016-2026F10.3.1.1.Market Size & Forecast10.3.1.1.1By Value10.3.1.2.Market Share & Forecast10.3.1.2.1.By Technology10.3.1.2.2.By Type10.3.1.2.3.By Application10.3.1.2.4.By End User

‹#›

Table of Contents

S. No.ContentsPage No.10.3.2.Argentina Biochip Market Outlook, 2016-2026F10.3.2.1.Market Size & Forecast10.3.2.1.1By Value10.3.2.2.Market Share & Forecast10.3.2.2.1.By Technology10.3.2.2.2.By Type10.3.2.2.3.By Application10.3.2.2.4.By End User10.3.3.Colombia Biochip Market Outlook, 2016-2026F10.3.3.1.Market Size & Forecast10.3.3.1.1By Value10.3.3.2.Market Share & Forecast10.3.3.2.1.By Technology10.3.2.2.2.By Type10.3.2.2.3.By Application10.3.2.2.4.By End User

‹#›

Table of Contents

S. No.ContentsPage No.11.Middle East & Africa Biochip Market Outlook, 2016-2026F11.1.Market Size & Forecast11.1.1.By Value11.2.Market Share & Forecast11.2.1.By Technology11.2.2.By Type11.2.3.By Application11.2.4.By End User11.2.5.By Country 11.3.Middle East & Africa : Country Analysis11.3.1.South Africa Biochip Market Outlook, 2016-2026F11.3.1.1.Market Size & Forecast11.3.1.1.1.By Value11.3.1.2.Market Share & Forecast11.3.1.2.1.By Technology11.3.1.2.2.By Type11.3.1.2.3.By Application11.3.1.2.4.By End User

‹#›

Table of Contents

S. No.ContentsPage No.11.3.2.Saudi Arabia Biochip Market Outlook, 2016-2026F11.3.2.1.Market Size & Forecast11.3.2.1.1.By Value11.3.2.2.Market Share & Forecast11.3.2.2.1.By Technology11.3.2.2.2.By Type11.3.2.2.3.By Application11.3.2.2.4.By End User11.3.3.UAE Biochip Market Outlook, 2016-2026F11.3.3.1.Market Size & Forecast11.3.3.1.1.By Value11.3.3.2.Market Share & Forecast11.3.3.2.1.By Technology11.3.3.2.2.By Type11.3.3.2.3.By Application11.3.3.2.4.By End User

‹#›

Table of Contents

S. No.ContentsPage No.12.Market Dynamics (This chapter assesses the major demand drivers and restraints.)12.1.Drivers12.2.Challenges13.Market Trends & Developments (This section captures recent trends pertaining to manufacturing or consumption, market movements in terms of points of production and consumption, advancements and development)14.Competitive Landscape 14.1.Competition Outlook14.2.Global Players Profiled (Leading Companies)14.2.1. Company DetailsCompany Details14.2.2. Products & ServicesProducts & Services14.2.3. Financials (As Reported)Financials (As Reported)14.2.4. Key Market Focus & Geographical PresenceKey Market Focus & Geographical Presence14.2.5. Recent DevelopmentsRecent Developments14.2.6. Key Management PersonnelKey Management Personnel15.Strategic Recommendations (Based on the findings of the report strategic recommendations on how to enter and expand market share)16.About Us & Disclaimer

‹#›

RESEARCH

METHODOLOGY

Research Methodology

Identifying Key Opinion Leaders

Questionnaire Design

In-depth Interviews

Data Collection

Developing List of Respondents

Formulating Questionnaire

Market Profiling

Data Validation

Data Analysis

In-depth secondary research was conducted to determine top players in the global biochip market, overall market size and segmental market size.

In order to conduct industry experts’ interviews, TechSci formulated a detailed discussion guide.

List of industry players and industry specialists was developed.

TechSci conducted interviews with industry experts and industry players for data collection and verification.

Data obtained as a result of primary and secondary research was validated through rigorous triangulation.

The data was scrutinized using MS-Excel, statistical tools and internal proprietary database to obtain qualitative and quantitative insights about the global biochip market.

Data

Collection

Data Filter

& Analysis

Research &

Intelligence

Actionable

Insights

Business

Solution

Primary Research

Desk Research

Company Analysis

Recent Developments

Market Changing Aspects/Dynamics

Government Policies

Conclusion

Market Participants

Key Strengths

LinkedIn

TechSci Internal Database

Factiva

Hoovers

Paid Sources

Company Websites

Company Annual Reports

White Paper Study

Financial Reports

Investor Presentations

Regulatory Body

Associations, etc.

Secondary Research

Primary Research

‹#›

Research Methodology

Baseline Methodology

Our dedicated team of industry experts has monitored and analyzed various aspects of the global biochip market. The team has analyzed the outlook of various segments of this market, while considering the major influencing factors such as increase use of biochip. The study includes market forecasting, which would enable our clients to take better decisions while planning their strategy to achieve sustainability in the global biochip market.

Methodology Followed for Calculation of Market Size:

Market Size by Value & Volume : Market size, in terms of value, for the year 2020 was calculated based on information collected through exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as biochip manufacturers, channel partners, market influencers & end users, industry experts, and other industry participants.

The team interviewed more than 15 – 20 biochip manufacturers, 100 – 120 end users, and 15 – 20 industry experts and other value chain stakeholders in the global biochip market to obtain the overall market size from 2016 to 2020, which was validated by the Delphi technique. Taking standard deviation into consideration, the market size was averaged out, to arrive at the market size data during 2016-2020.

‹#›

Research Methodology

Respondents were asked about the current and future market growth rates, market shares by technology, by type, by application, by end user, by company and by each region. Removing the outlier responses, the geometric mean of growth estimates and provider wise revenue shares generated across various segments were considered, to arrive at the final revenue shares. Revenue shares generated across various type were further triangulated from other stakeholders.

Methodology Followed for Calculation of Market Shares:

Market shares by technology, by type, by application, by end user, by company and by each region were calculated based on the responses received through primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated from various types of biochip. The final shares were calculated by taking the geometric mean of the responses gathered from key opinion leaders after eliminating the outliers.

Methodology Followed for Forecasting:

TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in SPSS/Tableau Software.

Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast global biochip market, TechSci Research used various forecast techniques such as:

Moving Average

Time Series Analysis

Regression Analysis

Econometric and Judgmental Analysis

‹#›

Research Methodology

TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used the impact analysis during short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that the figures compiled are only for the organized market including market share data. The currency used in the report is the United States Dollar (USD), with the market size indicated in USD million.

Partial List of Companies Interviewed Key Secondary SourcesAbbott Laboratories Ltd.Agilent Technologies, Inc.PerkinElmer Inc.Fluidigm CorporationIllumina, Inc.GE Healthcare Inc.Bio-Rad Laboratories Inc.Thermo Fisher Scientific, Inc.F. Hoffmann-La Roche AGBioMérieux SAHoriba, Ltd.Qiagen N.V.Randox Laboratories Ltd.OriGene Technologies, Inc.CepheidWorld BankInternational Monetary Fund (IMF)TechSci Research Proprietary Database & Knowledge RepositoryCompany Annual Reports Industry MagazinesIndustry ReportsNews DailiesCredible Paid Databases

‹#›

Industry Brief

According to TechSci Research report, “Global Biochip Market By Technology (Microarray v/s Microfluidics), By Type (DNA Chips, Lab-On-a-Chips, Protein Chips, Others), By Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Others), By End User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes, Others), By Company, By Region, Forecast & Opportunities, 2026”, the biochip market was valued at USD11694.24 million in 2020 and is expected to reach USD23890.58 million by registering a CAGR of 12.52%. The increasing prevalence of various chronic diseases like cancer, immunological disorders and other infectious diseases, especially among the geriatric population is acting as a major growth factor for the global biochip market. Moreover, the rising demand for targeted therapies and personalized medicines, extensive R&D activities and supportive government policies are some other key factors supporting the global biochip market growth. Furthermore, ongoing technological innovations and new product launches by major players operating in the market are expected to create lucrative growth opportunities for the market over the next five years. Additionally, biochips are also finding applications in the field of genomics, genotyping and proteomics. This in turn is likely to positively influence the market growth through 2026. Apart from that, various economies are increasing spending on clinical research which is further augmenting the growth of the global biochip market. However, the high cost of biochips and lack of awareness especially in developing and underdeveloped countries can hamper the market growth.

The global biochip market is segmented based on type, technology, application, end user and region. Based on end user, the market can be fragmented into biotechnology & pharmaceutical companies, hospitals & diagnostics centers, academic & research institutes, and others. The hospitals & diagnostic centers segment dominated the market in 2020 by holding 40.53% of the market share and is expected to maintain its leading position in the market on account of the extensive use of biochips by them. This can be ascribed to the associated advantages of biochips such as affordability, time saving and ability to deliver high throughput without requiring instruments. In terms of application, the market is fragmented into drug discovery & development, disease diagnostics, genomics, proteomics, others. Out of which, the drug discovery & development application segment held the largest market share in 2020 on account of the growing development of targeted and personalized medicines for treating cancer. Also, the disease diagnostics segment is projected to witness the highest growth in the forthcoming years due to the rising demand for the detection and diagnosis of genetic disorders across the globe. Based on type, the market can be categorized into DNA Chips, Lab-On-a-Chips and Protein Chips. Out of which, the DNA chips segment dominated the market in 2020 on account of its widespread adoption and use of DNA chip products. Moreover, increased spending on research related to genomics and next-generation sequencing is further contributing to the growing demand for DNA biochips.

Major players operating in the global biochip market are Abbott Laboratories Ltd., Agilent Technologies, Inc., PerkinElmer Inc., Fluidigm Corporation, Illumina, Inc., GE Healthcare Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG, bioMérieux SA, Horiba, Ltd., Qiagen N.V., Randox Laboratories Ltd., OriGene Technologies, Inc., Hologic, Inc., among others. Companies are investing in developing advanced technologies and launching new services in order to enhance their product portfolio and are also undergoing inorganic growth strategies such as mergers & acquisitions, strategic partnerships, collaborations and joint ventures.

“Regionally, North America is expected to dominate the global biochip market through 2026 on account of growing prevalence of various sedentary lifestyle associated diseases in the countries like United States and Canada. However, the Asia Pacific region is expected to register the fastest CAGR during the forecast period owing to the growth in life science industry and improving healthcare facilities in the region. Additionally, major players operating in the market are expanding their business in the region especially in countries like India and China, positively influencing the growth of the market.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

‹#›

22

Sample Data - Snaphshot

Global Biochip Market Size, By Value (USD Million), 2016–2026F

CAGR BY VALUE: XX%

CAGR BY VALUE: XX%

Asia-Pacific Biochip Market Share, By Technology, By Value, 2016–2026F

India Biochip Market Share, By Type, By Value, 2016–2026F

‹#›

23

By Value (USD Million)

201620202021E2026F56789101112131415

Microarray

201620172018201920202021E2022F2023F2024F2025F2026F0.50.50.50.50.50.50.50.50.50.50.5Microfluidics

201620172018201920202021E2022F2023F2024F2025F2026F0.50.50.50.50.50.50.50.50.50.50.5

DNA Chips

201620172018201920202021E2022F2023F2024F2025F2026F0.250.250.250.250.250.250.250.250.250.250.25Lab-On-a-Chips

201620172018201920202021E2022F2023F2024F2025F2026F0.250.250.250.250.250.250.250.250.250.250.25Protein Chips

201620172018201920202021E2022F2023F2024F2025F2026F0.250.250.250.250.250.250.250.250.250.250.25Others

201620172018201920202021E2022F2023F2024F2025F2026F0.250.250.250.250.250.250.250.250.250.250.25

Report Ordering

Report Name: GLOBAL BIOCHIP MARKET

FORECAST & OPPORTUNITIES

2016 – 2026

To View Sample OR Purchase Report

 

License Type Price Single User License$4450Multi-User License$5450Custom Research License$9450

‹#›

24

About Us & Disclaimer

TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in number of areas to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality reports. The proprietary forecasting models use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ model of a country, regional and global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market.

Related Reports

Global Coronavirus Vaccine Market By Infection Type (HCoV-229E, HCoV-OC43, SARS-CoV, New Haven CoV, HKU1-CoV, MERS-CoV, SARS-CoV-2, Others), By Vaccine Type (Inactivated Coronavirus Vaccine, Live Attenuated Coronavirus Vaccine, S-Protein Based Coronavirus Vaccine), By Product Type (Monovalent Vaccine v/s Multivariant Vaccine), By Route of Administration (Oral, Intramuscular, Subcutaneous), By Patient Type (Pediatric v/s Adult), By End User (Hospitals, Clinics, Research Institutes, Others), By Region, Forecast & Opportunities, 2026

Global 3D Mobile C-Arm Market By Application (Orthopedics, Trauma, Cardiovascular, Urology, Gastroenterology, Neurology, Others) By End Users (Hospitals, Specialty Clinics, Ambulatory Surgical Clinics) By Region, Competition Forecast & Opportunities, 2026.

The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research.

TechSci Research – North America

708 Third Avenue, Manhattan,

New York, United States

Tel: +1- 646- 360- 1656

Email: [email protected] www.techsciresearch.com

Disclaimer

TechSci Research – Europe

54, Old brook, Bretton,

Peterborough,

United Kingdom

Email: [email protected] www.techsciresearch.com

TechSci Research – Asia-Pacific

B – 44, Sector – 57, Noida, National Capital Region, U.P. - India

Tel: +91-120-4523900

Email: [email protected] www.techsciresearch.com

25